The Carolina Cancer Nanotechnology Training Program is an NIH funded 24-36-month mentored training program offered at The University of North Carolina Chapel Hill with focus area of research on cancer nanotechnology. Join an elite group of scientists and innovators using multidisciplinary concepts and skills to improve cancer diagnosis and therapy based on tools and discoveries made in nanoscience and nanotechnology.
All applicants must be either US citizens or permanent residents.
Strong emphasis on cancer biology and clinical medicine in addition to nanotechnology. Program focus areas include: drug delivery, polymers, chemo- and immunotherapy, RNA vaccines, computational chemistry, PK/PD, and translational research. Curriculum of seminars and workshops developed to broaden understanding of all areas of cancer nanotechnology. Physical and material scientists, pharmaceutical scientists, biomedical engineers, and clinician scientists all strongly encouraged to apply.
Trainee will have completed highly relevant doctoral training in medical, pharmacy, chemistry, biomedical sciences, or related area and was awarded Ph.D., M.D. or M.D./Ph.D.
Please refer to the program website for additional details.
Any questions or inquiries can be directed to Amy Fry at email@example.com.